Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Astellas Pharma Inc.
  6. Financials
    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Capitalization1 3 186 2313 105 3953 161 4213 500 442--
Entreprise Value (EV)1 2 875 1572 777 5452 829 7333 022 8642 689 3962 436 689
P/E ratio 14,4x16,0x26,2x17,7x14,7x12,5x
Yield 2,29%-2,47%2,65%2,92%3,34%
Capitalization / Revenue 2,44x2,39x2,53x2,64x2,50x2,32x
EV / Revenue 2,20x2,14x2,26x2,28x1,92x1,62x
EV / EBITDA 9,35x8,95x13,6x9,26x7,27x5,77x
Price to Book 2,49x2,41x2,28x2,36x2,18x2,00x
Nbr of stocks (in thousands) 1 921 1521 858 4051 857 4741 853 066--
Reference price (JPY) 1 6591 6711 7021 8891 8891 889
Announcement Date 04/25/201905/14/202004/27/2021---
1 JPY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net sales1 1 306 3481 300 8431 249 5281 324 9421 400 5251 506 544
EBITDA1 307 370310 387208 703326 583369 854421 993
Operating profit (EBIT)1 243 912243 991136 051250 219297 843345 232
Operating Margin 18,7%18,8%10,9%18,9%21,3%22,9%
Pre-Tax Profit (EBT)1 248 967245 350145 324246 449298 986343 475
Net income1 222 265195 411120 589195 732233 581269 367
Net margin 17,0%15,0%9,65%14,8%16,7%17,9%
EPS2 11510464,9106128151
Dividend per Share2 38,0-42,050,055,263,2
Announcement Date 04/25/201905/14/202004/27/2021---
1 JPY in Million
2 JPY
Income Statement Evolution (Quarterly data)
Fiscal Period: March 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3
Net sales1 325 427308 621326 143327 786653 900348 300
EBITDA ------
Operating profit (EBIT)1 72 598-23 41936 09068 403138 20072 633
Operating Margin 22,3%-7,59%11,1%20,9%21,1%20,9%
Pre-Tax Profit (EBT)1 75 136-18 90335 83075 500143 20073 500
Net income1 60 079-12 32830 68758 900113 70057 300
Net margin 18,5%-3,99%9,41%18,0%17,4%16,5%
EPS2 32,4-6,6316,628,561,432,6
Dividend per Share ------
Announcement Date 01/29/202104/27/202107/30/2021---
1 JPY in Million
2 JPY
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt1 ------
Net Cash position1 311 074327 850331 688477 578811 0461 063 753
Leverage (Debt / EBITDA) -1,01x-1,06x-1,59x-1,46x-2,19x-2,52x
Free Cash Flow1 233 440-167 795275 459253 942240 208259 123
ROE (Net Profit / Equities) 17,6%15,3%9,00%13,9%16,0%17,5%
Shareholders' equity1 1 262 8691 277 1961 339 8781 406 9871 455 7891 542 560
ROA (Net Profit / Asset) 13,3%11,6%6,33%9,35%10,9%11,7%
Assets1 1 676 5161 678 8581 905 1212 094 2012 143 1452 296 541
Book Value Per Share2 667694748800867946
Cash Flow per Share2 148140104135156170
Capex1 25 19041 26731 38432 67746 86949 347
Capex / Sales 1,93%3,17%2,51%2,47%3,35%3,28%
Announcement Date 04/25/201905/14/202004/27/2021---
1 JPY in Million
2 JPY
Key data
Capitalization (JPY) 3 500 442 278 480
Capitalization (USD) 31 854 926 229
Net sales (JPY) 1 249 528 000 000
Net sales (USD) 11 358 209 520
Number of employees 15 455
Sales / Employee (JPY) 80 849 434
Sales / Employee (USD) 734 921
Free-Float 98,9%
Free-Float capitalization (JPY) 3 463 384 723 844
Free-Float capitalization (USD) 31 517 692 938
Avg. Exchange 20 sessions (JPY) 9 124 650 157
Avg. Exchange 20 sessions (USD) 82 943 070
Average Daily Capital Traded 0,3%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA